Dr. Guarav Gupta, a transplant nephrologist, explained that the clinical trial uses a deceased donor’s kidney infected with Hepatitis C, “Put them into patients without Hepatitis C and then, either eradicate the virus up front or treat if the patient develops an infection.”
Dr. Richard Sterling is Chief of Hepitology. He said patients got two doses of a Hepatitis C medication, “Both on the day of the transplant and the following day. We know that we can cover the patient’s Hepatitis C regardless of the type that they got.”
Six VCU Health patients have had successful transplants and the two that tested positive underwent 12 weeks of treatment with a genotype-specific drug and they are now free of Hepatitis C.